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ABSTRACT
Objective: To determine the magnitude of the rosclerotic arterial disease in Rheumatoid 
Arthritis(RA) patients at Kenyatta National Hospital. 
Design: Hospital based cross-sectional study. 
Setting: Kenyatta National Hospital Rheumatology outpatient clinic.
Subjects: Rheumatoid Arthritis patients.
Results: We obtained ABI measurements in 90 RA patients, among them 23(25.5% 95% 
CI 17.2-36.1) had obstructed lower limb arteries. Among the 23, 21(91.3%) had mild PAD, 
two (8.7%) had moderate PAD; none had severe PAD nor incompressible vessels. The 
obstruction of vessels was independent of diabetes, hypertension, dyslipidemia and 
cigarette smoking though these factors increased the likelihood of having PAD. Risk 
age( ≥45 males, ≥55 females), Established RA(> 5 year duration) and severe RA were 
found to be significantly associated with the likelihood of having PAD. These trends 
remained significant after multivariable adjustment for potential confounders. twenty 
five (27.7%) of the study subjects exhibited symptoms of intermittent claudication, 
13(52%) of them had PAD on ABI measurements, The Edinburgh claudication 
questionnaire was found to have 56.5% sensitivity and 82% specificity in detection 
of PAD in RA patients.
Conclusion: There seems to be an association between PAD in RA with chronicity and 
severity of the RA. This association may support the pathogenic role of accumulated 
systemic inflammation in atherosclerosis. Clinicians should be alert to the possibility of 
impared arterial function and thus subsequent cardiovascular morbidity and mortality 
in this group of patients.
INTRODUCTION
Rheumatoid Arthritis (RA) emerges as a major cause 
of significant morbidity and increased mortality 
which plagues the normal lives of millions of people 
all over the world. Early diagnosis of RA and prompt 
initiation of standard treatment has shown to improve 
prognosis and quality of life (1).
Patients with Rheumatoid arthritis apart from leading 
to irreversible joint damage and functional disability, 
have a two to five times increased risk of developing 
premature cardio-vascular disease that shortens life 
expectancy by five to ten years . It has been suggested 
that this excess mortality is mainly due to cardio-
vascular disease (CVD) which accounts for nearly 
50% of death causes (35-50%) (2,3).
Pooled analysis of many observational studies suggest 
an increase in risk of death in RA associated cardio-
vascular disease (CVD) and that this has a prognosis 
comparable to that of triple-vessel Coronary Heart 
Disease (CHD) or stage 4 Hodgkin’s disease (3). 
Intriguingly, most evidence suggests that classic 
cardio-vascular risk factors do not fully explain this 
excess vascular disease in RA (4, 5). 
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 The risk of CVD associated with RA has been 
equalled to that of Type 2 Diabetes mellitus. Hence, 
RA itself should be regarded as a strong independent 
cardio-vascular risk factor for which cardi-ovascular 
risk management, as in DM2, should be considered 
(6).
 Peripheral arterial disease (PAD) is a term 
mainly used to refer to a manifestation of systemic 
atherosclerosis. Data across many studies support the 
finding of PAD cross-sectionaly relating to cardio-
vascular morbidity and mortality independent of 
other adjusted risk factors. Patients with PAD have a 
15–30% five year mortality rate and a two to six fold 
increased risk of death from coronary heart disease. 
Mortality being highest in those with more severe 
PAD (7).
 Recognition of PAD in clinical practice is 
important since it identifies patients at high risk of 
subsequent cardio-vascular and cerebro-vascular 
events and elicits symptoms of PAD which may be 
associated with functional disability and limb loss 
(9).
 Detection of Ankle Brachial Index (ABI) is a 
standardised, non-invasive, simple reproducible 
and cost-effective method for detection of Peripheral 
Arterial disease and provides objective data both for 
the diagnosis and monitoring of efficacy of therapeutic 
interventions. American College of Cardiology 2005 
guidelines state that the initial responsibility for 
the detection of PAD should be with primary-care 
providers, who are best positioned to determine an 
at-risk population and to initiate cardio-vascular risk 
reduction therapies (9).
 Despite recent interest in cardio-vascular disease 
in Rheumatoid arthritis, the peripheral arteries 
have been understudied. Central atherosclerosis 
has been extensively proven especially using the 
carotid intima media thickness studies (CIMT) (10). 
Few studies done have documented an increased 
prevalence of impaired peripheral artery function 
in RA patients. Peripheral arterial disease is not 
most common recognised clinically in Rheumatoid 
arthritis, perhaps because the sedentary life caused by 
musculoskeletal impairment may not favour exercise 
induced ischaemic symptoms. Pain symptoms may 
also be mistaken for osteoarticular pain (11,12).
 
MATERIALS AND METHODS
We performed a cros-sectional analysis of data 
collected from Rheumatoid arthritis patients attending 
the rheumatology clinic at the Kenyatta National 
Hospital. Our institutional review board approved 
the study and all patients gave written, informed 
consent to participate in the study. From December 
2010 to March 2011, we enrolled consecutive patients 
who met the 1987 American college of rheumatology 
RA classification criteria and confirmed by consultant 
rheumatologist at time of diagnosis. The principal 
investigator reviewed the medical records and 
administered the questionnaire. We ascertained age, 
sex, marital status, residence, education level and 
employment status all by self-report. We recorded 
dates of symptom onset and diagnosis of RA, 
history of chronic illness and confirmed these by the 
medical records. The principal investigator trained 
in examination techniques assessed for presence of 
pulses, abdominal and carotid bruits and performed 
Ankle Brachial Index(ABI) measurements. 
 We ascertained cardio-vascular risk factors 
as follows, diabetic if, self report of diabetes with 
supported records or use of hypoglycemic drugs 
with supporting file record of diabetes.
 Or a fasting blood glucose of >7mmol or 
random blood glucose of >11.1mmol. Hypertension 
if  known  with supporting records or on treatment 
for hypertension with supporting records. Or a 
Systolic BP> 140 mmhg or Diastolic BP >90 mmhg 
(13). Dysplipidemia if the condition is self reported 
with evidence of record and or treatment for it. 
Or an abnormality in any of the sub-types of the 
measured  lipid profiles and classified according to 
adult treatment panel III guidelines for management 
of serum lipids (14). Smoking status, current smokers 
if smoke at least 100 cigarettes in their lifetime and 
are still smoking or have quit within the preceding 
years.Formers smoker those who have smoked at 
least 100 cigarettes in their lifetime but quit smoking 
less than one year earlier and  non smoker as those 
who have smoked less than 100 cigarettes in their 
lifetime or who have never smoked (15).  Age as a 
cardio-vascular risk factor, men ≥ 45years, women ≥ 
55 years. Patients duration of illness (from onset of 
symptoms – time of study) was classified as early 
Rheumatoid arthritis zero to five years, established 
Rheumatoid Arthritis less than five years. A measure 
of adult general functional status will be used to 
measure disease severity. The routine assessment 
of patient index data three (RAPID 3) subset of 
the health assessment questionnaire (HAQ) which 
comprises disability index, the visual analogue pain 
scale and the visual analogue scale patient global 
assessment of health was used (16). The total score 
(0-30) from the three dimensions measured in the 
RAPID 3 questionnaire were entered as the patients 
RAPID 3 cumulative score. A conversion table was 
used to simplify the patient’s weighed RAPID three 
score and classify patients RA as near remission, low 
severity, moderate severity and high severity.
 We assessed arterial function by means of the 
ankle–brachial index (ABI), also known as the ankle-
to-arm systolic blood pressure ratio as described (17). 
We used a Doppler apparatus (model 841-A; Parks 
Medical Electronics, Aloha, OR) and a standard blood 
pressure cuff to detect the systolic blood pressure 
wave at the dorsalis pedis and posterior tibial arteries 
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on each lower limb. Thus, each patient could have 
up to four arterial measurements. We divided each 
lower limb artery systolic pressure by the average 
of the right and left brachial systolic pressures. The 
normal ABI lies between 0.91 and 1.30; ABI values 
≤0.9 suggest the artery is obstructed, and ABI values 
≥1.31 indicate incompressible vessels.
 Intemittent claudication was recorded as present 
or absent according to patients response to the 
Edinburgh claudication questionnaire (18).
 On the first contact patients five mililitres of 
blood was drawn from the anterior cubital fossa into 
a plain bottle (red cap) for lipid profiles and blood 
sugar measurements. The samples for the day were 
transported immediately to the Clinical medicine 
and Therapeutics laboratory. Non-haemolysed 
samples were centrifuged and the serum assayed 
with commercially available reagent kits. Erba 
spectrophotometer machine was used for both 
lipid profile and blood sugar assays. Results were 
printed out in strips, labelled and recorded in a book 
containing patient’s names and study number. Results 
confidentiality was maintained at all times.
Data handling and statistical analysis: we entered all 
collected data and managed it in a Data pre-designed 
Microsoft excel database. Statistical analysis was 
done using statistical package for social scientists 
(SPSS) version 16.0.  We calculated prevalence as: 
number of patients with PAD divided by patient total 
number and expressed as a percentage. Continuous 
data were presented as means, standard deviations, 
medians, proportions and frequencies. We performed 
univariate analysis for independent variables  and 
presented them as proportions and frequencies. 
We carried out bivariate analysis using chi-square 
test to determine associations between PAD and 
each of the cardio-vascular risk factors.Multivariate 
analysis was used to determine independence of the 
significant risk factors and was carried out using 
binary logistic regression model. Associations were 
considered significant at a P-value ≤ 0.05. Odds ratios 
were calculated as a measure of risk magnitude. Data 
were presented using descriptive statistics and also 
using tables and bar graphs.
RESULTS
In this four month study (December 2010 and 31st 
March 2011) targeting all the registered RA patients 
attending the KNH Rheumatology clinic, One 
hundred and seven patients confirmed to have 
rheumatoid arthritis from documentation in the file 
(ACR criteria and confirmed by a Rheumatologist) 
were consecutively screened for recruitment. 
Seventeen patients were not eligible for the study. Ten 
patients declined to be in the study, the main reason 
given was unwillingness to have blood drawn for 
laboratory tests (Figure 1).
Figure 1
Enrolment flow chart   
90 enrolled
107 screened 1 Leg oedema
1 ankle ulcer
6(six) age <18yrs
9 declined (no consent)17 not legible
Demographic characteristics of the study population: The 
mean age of the patients was 48years median age 50 
years and the age range 18 - 79 years. Most of the study 
participants were female 78 (86.7%) giving a female: 
male ratio of 6.5:1. The male patients (mean age 53 
years SD 17) were on average older than their female 
(mean age 47 years SD14) counterparts, but this was 
not statistically significant (p = 0.22) (Table1).
Table 1
Demographic characteristics of study participants 
Demographic features                                                 
Age in years   N(%)
 18-29 years 10 (11)
 >29-39 years 14(16) 
 >39-49 years   20 (22)
 >49-59 years 26(29) 
 >59-69 years  16(18)  
 >69-79 years  4(4) 
Mean 48  SD(14
Gender Male  12(13.3) 
 Female  78(86.7)
 Male mean age  53 SD(17)
 Female mean age 47 SD(14)
Residence Nairobi  34(38.7)
 Outskirts of Nairobi
 (central, eastern)  33(35.2)
 Distant from Nairobi   23(26.1) 
Employment   Employed 53(59) 
Status    Unemployed          37(41) 
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 The patients were grouped into ten year age 
categories. The peak age bracket for the patients was 
50-59 years. The peak female age was 50-59years 
which was decade earlier than that for males. Females 
were more predominant in the younger age groups 
of 18-39years while males predominated in the older 
group between 40-69 years (Figure 2).
Figure 2




























Peripheral arterial disease: All the 90 study patients 
underwent successful ABI measurement among them 
,twenty three had ABI of <0.9 computing for a PAD 
prevalence of 25.6% (95% CI, 17.2–36.1).                                             
 The mean age of PAD patients was higher 
than that of their non PAD counterparts 56(±12) yrs 
versus 45 (±14): p = 0.001.Twelve (12) of the study 
participants were men and more than half of them 
had PAD 7(58.3%), while PAD affected only 28.2% 
of the females study participants, gender prevalence 
difference in PAD was statistically significant: p= 
0.005.  
 All the patients were classified into categories 
based on PAD severity. Among the twenty three 
patients with PAD, majority had mild disease 
21(91.3%); none of the patients had severe PAD.            
Table 2
PAD severity by ABI classification
  Count (%)
ABI <=0.4 severe PAD 0 (0)
 0.41-0.7 moderate PAD 2 (2.2)
 0.71-0.9 mild PAD 21 (23.3)
 0.91-1.3 normal 67 (74.4)
 >1.3 non compressible 0 (0)
 Total 90 (100)
Clinical characteristics of the study population: 
Half the patients had established rheumatoid 
arthritis, while majority (87%) of patents with 
obstructed vessels had established RA. 
More than one third (40%) of the studied patients 
were found to be hypertensive while two thirds 
(61%) of those with abnormal vessels on ABI were 
hypertensive. Those found to be diabetic (14%) were 
almost equally distributed among those with normal 
and abnormal vessels (1:1.1). Only seven (8%) of the 
patients were tobacco smokers and again they were 
almost equally distributed in the group with normal 
vessels (4) and those with obstructed vessels (3). 
Majority of the patients were had dyslipidemia (74%) 
and this large proportion was reflected both in those with 
normal and abnormal vessels. The most common pattern 
was hypercholesterolemia among those with obstructed 
vessels and low HDL among those with normal vessels. 
One third (30%) of the studied patients were at cardio-
vascular risk by virtue of age, this consisted of 58% of 
the studied male patients and only 29% of the studied 
female patients. Among the male patients at risk age, 
only one of them was found to have normal vessels on 
ABI measurement. On average the studied patients had 
moderately severe RA. This moderate disease severity 
pattern was also elicited among each of the two patient 
groups. On an individual count basis only three (13%) 
of the patients with PAD had RA of low severity, while 
almost half (48%) of those with no PAD were found to 
have RA of low severity  (Table 3).  
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Table 3
Clinical characteristics of  study subjects  
  Ankle Brachial Index 
 All patients <0.9(obstructed) 0.9–1.3 (normal)
No of patients  90 23    67    
Duration of rheumatoid arthritis 
               Mean duration of RA 8(±6) 11(±4) 5(±6)   
 > 5years -established 
 disease 46(51) 20(87) 26(39)
Hypertension  36(40) 14(61) 22(33)
Diabetes  13(14) 6(26) 7(10) 
Dyslipidemia  67(74) 17(74) 50(75)
 Hypercholesterolemia 29(43) 10(59) 19(38)
 Hypertriglycerenemia 29(43) 7(41) 21(42)
 Low HDL 28(42) 6(35) 22(44)
Smoking  7(8) 3(13) 4(6)    
Cardiovascular risk age ( > 45 years Male >55years female) 
                        Male 7(8) 6(26) 1(2)
                        Female 22(24) 8(35) 14(21)
Rheumatoid arthritis severity score(Rapid 3) 
     Moderate- highly 
 severe disease 56 (62) 20 (87) 36 (64)
     Mean  score
 (interpreted score)  9.1(moderate disease) 12.1(moderate) 8 (moderate)
ABI<0.9    23(25.6%)
Mean age  56(±12)* 45(±14)
Males  7(30)  **5(7)
Intermittent claudication  13(52) 12(48)
Values are number(percentage) unless otherwise indicated
* P=0.001 versus normal ABI
**P=0.005 versus females with PAD
Number of cardio-vascular risk factors per patient: There 
was a step wise rise in the number of patients with 
PAD with the cumulative increase in number of CV 
risk factors. There was no PAD patient with zero CV 
risk factors. A large proportion (82%) of PAD patients 
each had ≥3 risk factors. When number of risk factors 
was compared between the two groups, there was 
statistical significance (p= <0.0001) (Figure 3).
Figure 3
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PAD risk association: As a measure of association 
between PAD and the cardio-vascular risk factors, 
bivariate analysis using Chi-square test was carried 
out. Odds ratios were calculated as a measure of 
risk magnitude of getting PAD when exposed to 
the risk factors. The likelihood of getting PAD 
when exposed to the cardio-vascular risk factors of 
interest was more than two fold for each risk factor 
except for dyslipidaemia. Statistical significance was 
however obtained in only three of the risk factors 
namely mod-severe RA, established RA, and risk 
age (Table 4).
Table 4
PAD and Cardiovascular risk factor association
Risk factor Odds ratio(95% CI) P-value
Risk age/not at risk age ( ≥45 male ≥55 female) 5.4(1.9-14.9) 0.001
Established/ early rheumatoid arthritis 10.5(2.8-38.9) <0.0001
Mod-high/ low rheumatoid arthritis severity 5.7(1.6-21.2) 0.005
Dyslipidemia/no dyslipidemia 0.96(0.4- 3.1) 0.946
Hypertension/no hypertension 3.3(0.9-6.6) 0.074
Diabetes/ no diabetes 3.0(0.9-10.2) 0.066
Cigarette smoking/no cig. Smoking 4.9(0.8-31.3) 0.069
 Multivariate analysis using binary logistic 
regression model was carried out to determine risk 
factors independently associated with the presence 
of PAD among those that were significant at bivariate 
analysis (Table 4). The three factors retained statistical 
significance as follows age (p = 0.04), Established 
disease (> five years disease duration) (p = 0.001) and 
moderate-severe disease severity (p= 0.013) (Table 
5).
Table 5
Multivariate analysis for risk age, disease severity and 
disease duration
Variable OR (95% CI) P-value
Risk age 3.3 (1.0 - 10.9)  0.047
Established 
RA(>5yrs)  9.9 (2.5 – 40.1)  0.001
RA Severity
(moderate–severe)  6.2 (1.5-25.8) 0.013
Symptomatic PAD: All 90 study participants 
were subjected to the Edinburgh claudication 
Questionnaire, 27.8% (95% CI 18.9-38.2) of them 
were found to have symptoms consistent with 
intermittent claudication. Half (52%) of those who 
exhibited symptoms of intermittent claudication were 
found to have PAD by virtue of an abnormal ABI. 
Presence of intermittent claudication was associated 
with up to a five fold risk of getting PAD using ABI 
measurement and this was of statistical significance 
(p= < 0.0001).
 Intermittent claudication when measured using 
the Edinburgh questionnaire was found to be 56.5% 
sensitive and 82% specific in determining presence 
of ABI diagnosed PAD in RA patients (Table 6).
Table 6
Intermittent Claudication and ABI association
Intermittent  Abnormal  Normal ABI  Total  P-value  OR(95%CI)
Claudication by  ABI (PAD)  (No PAD)
Edinburgh questionnaire n (%) n (%)  
Yes 13(52) 12(48) 25 <0.0001 5.9(2.1-16.8)
No 10(15) 55(85) 65
Total 23 67 90
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DISCUSSION
RA is a chronic systemic inflammatory disease 
which has also been associated with excess cardio-
vascular morbidity and mortality. Information on the 
prevalence of cardio-vascular disease in rheumatoid 
arthritis locally is unavailable. 
 In this study we sought evidence of peripheral 
atherosclerosis by ankle brachial index in RA patients. 
Using the technique of measuring ABI as a marker 
of atherosclerotic burden and a strong predictor of 
cardio-vascular morbidity and mortality. This is the 
first study of this nature done locally in this group 
of patients.
 From our results we found a young study 
population of mean age 48 years of whom over two 
thirds were women. Our results showed a significant 
proportion (25% prevalence) of PAD mainly 
comprising of mild disease. Our PAD population 
was found to be significantly older, have had RA for a 
longer duration and to have had more severe disease 
as compared to their non PAD counterparts and the 
same three factors were found to be independently 
associated with PAD.
 The number of patients with rheumatoid arthritis 
attending KNH MOPC seems to have significantly 
increased over the years. While in this study we were 
able to enrol 90 patients over a period of three months, 
Bagg et al (19) was only able to see 76 patients over 18 
months in 1979. Owino et al was able to see 60 patients 
within a period of six months at KNH MOPC (20). 
This increase could possibly be attributed to increased 
awareness of the disease, improved referral systems 
in the country and establishment of a rheumatology 
clinic at Kenyatta National Hospital in 2010. The more 
recent worldwide trends in RA incidence are not well 
known, however the incidence and prevalence of RA 
in populations has been noted to vary substantially 
between geographical areas and over time (21).
 In this study, females were 83.7% and the male to 
female ratio 1:6.5. This female gender preponderance 
has also been found in non local studies and confirms 
previous observation of the same. The mean age of 
male patients in our population 53(±17) years was 
higher than that of female patients 47 (±14) this 
age differences though not statistically significant 
coincides with what has been shown regarding the 
disease pattern affecting females at a younger age 
than males. 
 The mean age of our patients 48(±14) years was 
similar to that observed in an earlier local study by 
Kirui (22) (44.7 years) who in 2008-2009 identified 
traditional cardio-vascular risk factors in RA patients. 
The age characteristics found in these local studies 
was however younger compared to that recorded in 
a study of 353 RA patients in a Netherlands study 
comparing RA and diabetes as cardio-vascular risks 
(mean age of 63 years) (6). The difference could 
probably be explained by better health seeking 
behaviour of the elderly accompanied by better 
quality of health care systems and also a generally 
higher life expectancy all seen in these western 
countries. A racial difference could also explain this 
difference in age since a similar younger age group 
in black patients have been recorded in Nigeria by 
Adebajo when he compared the pattern of RA in west 
Africans with that of a cohort of British patients (23). 
This could be a pointer showing blacks get rheumatoid 
arthritis at an early and productive age group and 
thus more aggressive treatment needed.
 The PAD prevalence amongst RA patients in this 
study was 25.5%. This finding is similar to a study in 
Texas by I Del Rincon et al who examined lower limb 
arteries in age and sex matched (median age 59 years) 
non smoking subjects with and without rheumatoid 
arthritis. They found 19% of the rheumatoid arthritis 
patients to have abnormal arteries by virtue of 
abnormal ABI (11). Another study with prevalence 
comparable to ours, was evaluating the association 
of bone cortical thickness to ABI involving 588 RA 
patients, 28% of the patients were found to have 
abnormal ABI (12). 
 Peripheral arteries in general are understudied 
and the same applies in rheumatoid arthritis. Our 
patient population has shown significant amount 
of peripheral arterial disease which in turn goes to 
show the high risk of cardio-vascular events faced by 
our patients which should put all clinicians on high 
alert for. 
 The comparability of our prevalence to that of the 
UK and USA RA populations may mean that PAD in 
RA may not be related to factors such as race, climate, 
feeding habits and poverty but to the disease related 
factors.
 Local studies looking for PAD in other diseases 
found a much less PAD prevalence, Maritim et al 
in 2006 studied CKD patients, 80% of whom had 
advanced CKD (stage ≥3) (24). They found a PAD 
prevalence of 11.9%, mainly comprising of mild 
and moderate disease. Mugambi et al found a 12% 
prevalence of PAD when they set out to stratify 
patients with diabetes into risk categories for foot 
ulceration (25). Our study could therefore probably 
suggest that RA carries an almost double risk of 
peripheral vascular disease and thus cardio-vascular 
morbidity as compared to other diseases known 
to have high cardio-vascular risk. However ABI 
measurements in age- and -sex matched patients in 
various disease categories would be ideal to study 
for further comparison. 
 Caro et al embarked on estimating the burden 
of cardio-vascular risk in terms of mortality and 
morbidity in patients with PAD (26). They found the 
PAD crude five year death rate stood at 33.2 % (26.6% 
for index myocardial infarction; 41.8% for index 
stroke). This translated to our patients would mean 
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25.5% of our rheumatoid arthritis patients could have 
an estimated five year death rate of 33.2% secondary 
to cardiovascular events.
 Our study differs from that of the USA based 
rheumatoid arthritis PAD studies in that our study 
had a sample size much smaller, period of study 
was much shorter and a younger patient population 
(11,12). However, prevalence as is known may 
not be affected by these factors. PAD has however 
been shown to be more prevalent in the black race 
compared to the whites (27). This racial factor could 
have confounded our finding of a high PAD burden. 
Rheumatoid arthritis still stands out as an additional 
and major risk factor since local PAD studies in 
blacks without rheumatoid arthritis patients have 
not recorded such high burden of disease
 Correlations have been made between PAD 
severity and patient morbidity and mortality. Majority 
of our patients with PAD (91.3%) were found to have 
mild vascular obstruction, none of them had severe 
obstruction. Other studies have however recorded 
more severe PAD in their RA patients. Roldán JF 
et al found 10% of their study population to have 
severe disease (12). These patients were older and 
had a higher percentage of cigarette smokers which 
could probably explain the finding of more severe 
disease. 
 The cumulative survival after five years among 
our patients with mild disease is expected to be about 
91%. That is 9% of these patients could have a cardio-
vascular death or suffer a cardio-vascular related 
morbidity if deduced from the finding of Sikkink et 
al  in determining the relationship between ABI and 
morbidity /mortality in patients with PAD (28).
 In this study we set out to find if specific (those 
demonstrated in previous studies) cardio-vascular 
risk factors are associated with PAD in rheumatoid 
arthritis. Detailed literature search has however 
revealed that both traditional and novel cardio-
vascular risk factors and disease-related mechanisms 
contribute to the RA atherosclerosis but the disease 
induced systemic inflammation is the major 
determinant of the RA vascular co-morbidity.
 A local study in 2008 by Kirui demonstrated 
a significant burden of cardio-vascular risk factors 
in rheumatoid arthritis patients; he found 87% of 
patients had traditional cardio-vascular risk factors 
(22).  
 We analysed age, duration of disease, severity 
of disease, hypertension, dyslipidemia, diabetes 
and cigarette smoking. Each of these factors was 
demonstrated in our patients. Most (82%) of the PAD 
patients had more than three of these risk factors 
and there was statistical significance (p<0.001) in 
comparing PAD verses non PAD patients in terms 
of number of cardiovascular risk factors. This is a 
pointer of that these risk factors increase the chance 
of patients developing PAD.
 On analysis of association, significant odds ratios 
were found in all risk factors except dyslipidaemia 
with the rest holding an equal or more than double 
risk of getting PAD. On multivariate analysis only 
cardio-vascular risk age (p=0.047), duration of RA 
disease (p=0.001) and disease severity of RA (p=0.013) 
were found to be independently associated with PAD 
in our study.
 The independence that we found in the above 
three factors goes to indicate that the increased arterial 
obstruction in our patients reflects the cumulative 
inflammatory disease process that is occurring in our 
patients. Our findings are similar to that proven in 
other studies. Fietta, P., et al found in their detailed 
search of the available literature that atherosclerosis 
is a common finding in RA patients and positively 
correlates with disease duration and severity (4).
 As a measure of disease severity we used the 
three dimensional routine assessment of patient 
index data three (RAPID 3) questionnaire was used. 
RAPID 3 is a time saving validated tool, a sub-set of 
the widely known five dimensional Health assessment 
questionnaire (HAQ) (16).This is the first time RAPID 
3 has been used in a study of this kind and has shown 
similar results to that of JK Alkaabi et al who showed 
patients with ABI < 1.0 to have higher HAQ scores 
(more severe disease) compared with normal ABI 
(29).
 Age as a cardio-vascular risk factor was 
independently associated with PAD in this study. 
Majority (67%) of our studied patients were not at 
cardio-vascular risk by virtue of age, however among 
those with PAD a significant two thirds (60.8%) 
were at enhanced risk by age. The prevalence of 
PAD increases with age: longevity also increases 
risk of cardio-vascular morbidity all as shown in 
the Framingham’s heart study. Our patients are thus 
facing a triple edged sword (age, longevity and RA) 
with risks for PAD and cardio-vascular mortality. Our 
study results also concurred with a study conducted 
in Spain which showed older age and disease duration 
as the best predictive factors for severe morphologic 
expression of atherosclerotic disease in RA patients 
(5). 
 The Quest RA study multivariate models found 
hypertension, dyslipidaemia, diabetes and smoking 
as independent factors associated with cardio-
vascular morbidity and mortality (30). As much as 
these factors have also been found to be strong risk 
factors of PAD, our study found no independent 
association between these three risk factors and 
PAD in rheumatoid arthritis patients. This apparent 
lack of association could be due to the fact that we 
had a small sample size and the number of patients 
with each of these risk factors was almost equally 
distributed among the PAD and the non PAD group, 
of note is that we did not calculate LDL levels since 
the lipid profiles obtained were spot and not fasting 
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and this is known to affect triglyceride levels. The 
studied population was also relatively young and 
also this being a descriptive study was possibly not 
sufficiently powered to assess traditional risk factors 
and associations. Our findings are also not surprising 
since a literature search reveals association but no any 
strong independence between these three risk factors 
and PAD in rheumatoid arthritis patients (11,31). 
 Accumulating clinical and epidemiological 
evidence suggests that the atherogenetic cardio-
vascular mortality and morbidity associated with 
RA is due to disease specific factors, rather than 
to ascertainment bias or to con-founders such as 
traditional cardio-vascular risk factors (4).
 Both asymptomatic and symptomatic peripheral 
arterial disease have been found to be consistent 
and powerful independent predictors of coronary 
and cerebrovascular events and mortality. Using the 
Edinburgh Claudication questionnaire (18) we found 
56% of our PAD patients exhibited a clinical picture 
compatible with intermittent claudication. On further 
analysis , intermittent claudication was found to be 
a predictor of abnormal ABI (p ≤ 0.001).
 If symptoms alone were to be used, a diagnosis 
of PAD could have been missed in 44% of the 
PAD patients diagnosed by ABI, this finding goes 
further to prove what has been documented before 
that in general, less than 20% of PAD patients are 
symptomatic; this makes symptoms not a useful 
tool in excluding PAD and also that the available 
intermittent claudication questionnaires have a low 
degree of sensitivity and therefore might tend to 
underestimate the true prevalence of intermittent 
claudication (18).
 Our patients however recorded a relatively 
high prevalence of intermittent claudication and this 
might have been confouded by the osteoarticular pain 
symptoms and painful neuropathy of multiple causes 
among rheumatoid arthritis patients being mistaken 
for intermittent claudication, hence the symptom of 
calf pain might not be a useful aspect to rely on in 
this patient population.
 We have documented a significant prevalence of 
impaired peripheral artery function in this sample of 
patients with rheumatoid arthritis. These findings are 
in line with existing evidence that patients with RA 
are prone to central and peripheral atherosclerosis. 
 We used the ABI, a simple, reliable and validated 
non-invasive technique, to assess the function of the 
lower limb arteries. 
 The increased frequency of arterial impairment 
that we have encountered in this rheumatoid 
arthritis group is apparently not explained for by 
most traditional cardiovascular risk factors. The 
associated factors that we have found could means 
that the patient with most severe rheumatoid 
arthritis and longer disease duration is more prone to 
occlusive atherosclerotic process. Thus our findings 
suggest that arterial impairments occur in patients 
with the greatest level of accumulated systemic 
inflammation. This supports a pathogenic role of 
systemic inflammation in atherosclerosis.
 One strength of the study is that we studied 
all the RA patients registered in the clinic at this 
point in time and that this RA cohort was a good 
representation of the RA population in the country, 
since patients Nairobi and outside Nairobi were well 
represented. The results of this study are thus unlikely 
to be explained by selection bias.
 Our data has extended earlier work in different 
fronts. This PAD finding is novel in that unlike in the 
western countries it has not been described before 
in RA patients locally and in Africa as a whole. In 
2009 cardio-vascular risk factors were described in 
RA patients; we have now gone ahead and shown 
presence of PAD (a cardio-vascular disease).
In conclusion, we set out to find the prevalence 
of PAD among our RA patients; we found a high 
prevalence (25%) which consisted mainly of mild 
PAD. PAD in this population was associated with 
age, duration of RA and severity of RA. Intermittent 
claudication as a symptom of PAD was only elicited 
among half (50%) of those RA patients who PAD. All 
clinicians should be alerted to look at rheumatoid 
arthritis patients as having a high cardio-vascular 
risk illness. Rheumatoid arthritis patients require 
early and aggressive management to reduce the risk 
of development of cardio-vascular disease. Those 
with chronic disease and severe disease are the most 
deserving of attention for symptoms and signs of 
atherosclerotic cardio-vascular disease.
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